Real World Evidence for MedTech Startups: Insights from Ian Weimer
For early-stage medtech companies, proving value often comes long before a product is built. In this conversation, Ian Weimer shares how real world evidence is shifting from a niche capability to essential infrastructure, and what that means for founders building in a changing regulatory and funding environment.
From Ideas to Execution: What a Week Reinforced for Our Work in Sioux Falls
From warming up space at Building 1 to engaging global innovators in Minneapolis, the 2026 Medical Alley Summit reinforced what matters most for South Dakota’s bioscience growth: focus, trust, and execution.
USD Discovery District Returns as Sponsor for 2026 Medical Alley Summit, Reinforces South Dakota’s Bioscience Momentum and National Connectivity
The USD Discovery District returns as a sponsor of the 2026 Medical Alley Summit, highlighting South Dakota’s growing role in bioscience innovation. The district will spotlight a new global case study on OmegaQuant and join a national conversation on the future of healthcare.